These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1323418)

  • 21. Prolactin response to fenfluramine is independent of serotonin release.
    McCann UD; Hatzidimitriou G; Ricaurte GA
    Eur J Pharmacol; 1996 Sep; 312(2):R1-2. PubMed ID: 8894606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
    Tao R; Fray A; Aspley S; Brammer R; Heal D; Auerbach S
    Eur J Pharmacol; 2002 Jun; 445(1-2):69-81. PubMed ID: 12065196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in rat striatal acetylcholine content by d-fenfluramine, a serotonin releaser.
    Consolo S; Ladinsky H; Tirelli AS; Crunelli V; Samanin R; Garattini S
    Life Sci; 1979 Dec; 25(23):1975-81. PubMed ID: 231171
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex.
    Sarkissian CF; Wurtman RJ; Morse AN; Gleason R
    Brain Res; 1990 Oct; 529(1-2):294-301. PubMed ID: 1704283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia.
    Jespersen S; Scheel-Krüger J
    J Pharm Pharmacol; 1973 Jan; 25(1):49-54. PubMed ID: 4146199
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term effects of fenfluramine on central serotonergic mechanisms.
    Steranka LR; Sanders-Bush E
    Neuropharmacology; 1979 Nov; 18(11):895-903. PubMed ID: 95210
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity.
    Halford JC; Harrold JA; Lawton CL; Blundell JE
    Curr Drug Targets; 2005 Mar; 6(2):201-13. PubMed ID: 15777190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphetamine and fenfluramine, two drugs for studies on food intake.
    Garattini S; Samanin R
    Int J Obes; 1978; 2(3):349-51. PubMed ID: 363632
    [No Abstract]   [Full Text] [Related]  

  • 30. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic regulation of acetylcholine release in rat frontal cortex.
    Hirano H; Day J; Fibiger HC
    J Neurochem; 1995 Sep; 65(3):1139-45. PubMed ID: 7643092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenalectomy enhances the anorectic effect of dexfenfluramine: relation to mineralocorticoids and salt appetite.
    Rowland NE; Dotson LM
    Physiol Behav; 1993 Aug; 54(2):203-6. PubMed ID: 8372110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of fenfluramine and fluoxetine on the acquisition of the conditioned avoidance response in rats.
    McElroy JF; Du Pont AF; Feldman RS
    Psychopharmacology (Berl); 1982; 77(4):356-9. PubMed ID: 6813897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotoninergic modulation of sodium appetite in the rat.
    Rouah-Rosilio M; Orosco M; Nicolaidis S
    Physiol Behav; 1994 May; 55(5):811-6. PubMed ID: 8022898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenfluramine discrimination in obese and lean Zucker rats: serotonergic mediation of effect.
    Schechter MD
    Eur J Pharmacol; 1986 Jun; 125(1):135-41. PubMed ID: 3732388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol intake of chickens treated with fenfluramine, fluoxetine, and dietary tryptophan.
    Lu MR; Wagner GC; Fisher H
    Alcohol Clin Exp Res; 1992 Oct; 16(5):852-6. PubMed ID: 1443420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
    Van de Kar LD; Urban JH; Richardson KD; Bethea CL
    Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.